China Shows Off COVID-19 Vaccines

Hamilton Nwosa
Writer

Ad

Ranked: U.S. Crude Oil Imports by Country

Key Takeaways In 2024, 61.7% of America’s crude oil imports were from Canada. Meanwhile, Mexico accounted for 7.1% of crude oil imports. Crude imports make up about 40% of the oil that is refined in America, much of which is heavier crude compared to America’s light oil. For decades, America was a net importer of…

Alleged N85 Billion Nigeria Air fraud: Ex-Minister Sirika Debunks Allegations

By Abiola Olawale The immediate-past Minister of Aviation, Hadi Sirika has spoken on the controversies surrounding the Nigeria Air project, a national carrier initiative that sparked widespread criticism. Speaking during an interview with Channels TV on Wednesday, Sirika dismissed claims of fraud and mismanagement. Sirika, during the interview rejected allegations of fraud, claiming that Nigeria…

Alphabet surges after court rejects DOJ’s call to break up Google in antitrust case

By Obinna Uballa Alphabet shares jumped 6% in premarket trading on Wednesday after a United States court rejected the Department of Justice’s (DOJ) push to break up Google in a high-stakes antitrust case. The DOJ had proposed divesting Google’s Chrome browser and imposing strict restrictions after the company was found last year to hold an…

Ad

China has put its homegrown covid-19 vaccines on display for the first time, as the country where the contagion was discovered looks to shape the narrative surrounding the pandemic.

High hopes hang on the small vials of liquid on show at a Beijing trade fair this week — vaccine candidates produced by Chinese companies Sinovac Biotech and Sinopharm.China COVID-19 Vaccines

Read also: COVID-19 Vaccine Coming Sooner Than Later, Says Trump

Neither has hit the market yet but the makers hope they will be approved after all-important phase 3 trials as early as year-end.

A Sinovac representative told AFP his firm has already “completed the construction of a vaccine factory” able to produce 300 million doses a year.

On Monday, people at the trade fair crowded around booths showing the potential game-changing vaccines.

China, which is facing a storm of foreign criticism over its early handling of the pandemic, has been trying to repurpose the story of Covid-19.

State media and officials are now emphasising the revival of Wuhan, the central Chinese city where the deadly pathogen surfaced, as a success story in the fight against the virus.

They are also touting progress on domestic vaccines as a sign of Chinese leadership and resilience in the face of an unprecedented health threat that has pummelled the global economy.

Read also: Huawei’s 5G Ban: China, UK In Fresh War Of Words

In May, President Xi Jinping pledged to make any potential vaccine developed by China a “global public good”.

The potential vaccines on display are among nearly 10 worldwide to enter phase 3 trials, typically the last step ahead of regulatory approval, as countries race to stub out the virus and reboot battered economies.

Sinopharm said it anticipates the antibodies from its jab to last between one and three years — although the final result will only be known after the trials.

China’s nationalistic tabloid Global Times reported last month that “the price of the vaccines will not be high”.

Every two doses should cost below 1,000 yuan ($146), the report said, citing Sinopharm’s chairman, who told media he has already been injected with one of the candidate vaccines.

China’s official Xinhua news agency reported Monday that another vaccine candidate, developed by Chinese military scientists, can deal with mutations in the coronavirus.

As of last month, at least 5.7 billion doses of the vaccines under development around the world had been pre-ordered.

But the World Health Organization has warned that widespread immunisation against Covid-19 may not be on the cards until the middle of next year.

AFP

Ad

X whatsapp